Capstone Therapeutics Stock Forecast

Hold candidate since Jul 31, 2026

The Capstone Therapeutics Corp stock price gained 5.37% on the last trading day (Friday, 31st Jul 2026), rising from $0.240 to $0.253. During the last trading day the stock fluctuated 11.06% from a day low at $0.235 to a day high of $0.261. The price has been going up and down for this period, and there has been a -1.59% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 48 thousand more shares were traded than the day before. In total, 87 thousand shares were bought and sold for approximately $22.02 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -33.12% during the next 3 months and, with a 90% probability hold a price between $0.147 and $0.184 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CAPS Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, July 24, 2026, and so far it has risen 9.81%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Capstone Therapeutics Corp has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Capstone Therapeutics Corp stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.260. On a fall, the stock will find some support from the short-term average at $0.244. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Capstone Therapeutics Corp stock

Capstone Therapeutics Corp finds support from accumulated volume at $0.253 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0260 between high and low, or 11.06%. For the last week, the stock has had daily average volatility of 6.76%.

Our recommended stop-loss: $0.243 (-4.00%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (CAPS) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Capstone Therapeutics Corp to open at $0.250, and during the day (based on 14 day Average True Range), to move between $0.243 and $0.263, which gives a possible trading interval of +/-$0.0201 (+/-8.29%) up or down from last closing price. If Capstone Therapeutics Corp takes out the full calculated possible swing range there will be an estimated 8.29% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.253 (0.16%) than the resistance at $0.294 (16.21%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Capstone Therapeutics Corp stock A Buy?

Capstone Therapeutics Corp holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.401 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $0.250 ( 1.32%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk